PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Strides Pharma Science Limited (STAR.NS)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

INE939A01011

Sector

Healthcare

Highlights

Market Cap

₹59.46B

EPS (TTM)

₹37.32

PE Ratio

17.29

Total Revenue (TTM)

₹45.26B

Gross Profit (TTM)

₹19.32B

EBITDA (TTM)

₹8.96B

Year Range

₹530.00 - ₹1,675.00

Target Price

₹1,373.00

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of ₹10,000 in Strides Pharma Science Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%SeptemberOctoberNovemberDecember2025February
-51.32%
12.99%
STAR.NS (Strides Pharma Science Limited)
Benchmark (^GSPC)

Returns By Period

Strides Pharma Science Limited had a return of -5.92% year-to-date (YTD) and -23.67% in the last 12 months. Over the past 10 years, Strides Pharma Science Limited had an annualized return of -2.55%, while the S&P 500 had an annualized return of 11.26%, indicating that Strides Pharma Science Limited did not perform as well as the benchmark.


STAR.NS

YTD

-5.92%

1M

-0.62%

6M

-51.28%

1Y

-23.67%

5Y*

4.54%

10Y*

-2.55%

^GSPC (Benchmark)

YTD

3.96%

1M

1.97%

6M

9.03%

1Y

22.16%

5Y*

12.60%

10Y*

11.26%

*Annualized

Monthly Returns

The table below presents the monthly returns of STAR.NS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20253.96%-5.92%
20247.62%12.57%-0.24%14.19%-3.93%10.23%12.68%25.33%4.59%11.19%5.13%-59.68%1.75%
2023-15.52%1.37%-4.42%18.91%5.52%19.86%9.64%-5.76%14.58%-6.15%2.06%33.41%86.21%
2022-11.79%-18.88%8.35%-5.31%1.31%-0.54%0.23%-0.32%0.53%-6.83%8.97%3.75%-21.74%
2021-7.29%2.40%1.33%2.37%-11.45%-0.84%1.48%-20.13%-3.90%-9.29%-8.77%-8.36%-48.93%
202028.28%1.26%-31.48%37.34%-9.94%2.80%7.01%38.50%19.10%-4.07%10.69%14.93%143.80%
20190.08%-8.77%10.66%2.97%-11.93%-5.56%-2.57%2.09%-19.29%25.11%0.68%-6.61%-18.29%
2018-7.28%-5.96%-6.74%2.17%-36.97%-1.80%-2.53%29.14%-12.07%-2.44%14.46%-5.08%-39.68%
20173.19%6.08%-5.52%-2.33%-15.64%10.55%5.83%-14.51%-1.66%-6.40%-3.61%3.02%-22.11%
2016-9.42%-24.69%23.25%-0.28%2.83%1.55%3.36%-18.18%5.75%3.98%4.73%-3.03%-17.32%
2015-2.87%-2.33%29.66%-12.85%22.86%-12.14%15.03%-3.77%-0.44%5.94%6.83%-6.70%34.65%
20144.26%-6.60%10.35%34.60%-3.26%24.03%5.90%-0.73%9.59%8.65%26.38%13.99%212.90%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of STAR.NS is 30, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of STAR.NS is 3030
Overall Rank
The Sharpe Ratio Rank of STAR.NS is 2828
Sharpe Ratio Rank
The Sortino Ratio Rank of STAR.NS is 3434
Sortino Ratio Rank
The Omega Ratio Rank of STAR.NS is 3636
Omega Ratio Rank
The Calmar Ratio Rank of STAR.NS is 2424
Calmar Ratio Rank
The Martin Ratio Rank of STAR.NS is 2626
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Strides Pharma Science Limited (STAR.NS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for STAR.NS, currently valued at -0.33, compared to the broader market-2.000.002.004.00-0.331.83
The chart of Sortino ratio for STAR.NS, currently valued at 0.11, compared to the broader market-6.00-4.00-2.000.002.004.006.000.112.47
The chart of Omega ratio for STAR.NS, currently valued at 1.02, compared to the broader market0.501.001.502.001.021.33
The chart of Calmar ratio for STAR.NS, currently valued at -0.35, compared to the broader market0.002.004.006.00-0.352.76
The chart of Martin ratio for STAR.NS, currently valued at -0.84, compared to the broader market-10.000.0010.0020.0030.00-0.8411.27
STAR.NS
^GSPC

The current Strides Pharma Science Limited Sharpe ratio is -0.33. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Strides Pharma Science Limited with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.006.00SeptemberOctoberNovemberDecember2025February
-0.33
2.28
STAR.NS (Strides Pharma Science Limited)
Benchmark (^GSPC)

Dividends

Dividend History

Strides Pharma Science Limited provided a 0.40% dividend yield over the last twelve months, with an annual payout of ₹2.50 per share.


0.00%2.00%4.00%6.00%8.00%10.00%12.00%₹0.00₹20.00₹40.00₹60.00₹80.00₹100.0020142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
Dividend₹2.50₹2.50₹1.50₹0.00₹2.50₹2.00₹15.00₹2.00₹4.50₹4.00₹3.00₹110.00

Dividend yield

0.40%0.38%0.23%0.00%0.56%0.23%4.14%0.43%0.59%0.40%0.25%12.29%

Monthly Dividends

The table displays the monthly dividend distributions for Strides Pharma Science Limited. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025₹0.00₹0.00₹0.00
2024₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹2.50₹0.00₹0.00₹0.00₹2.50
2023₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹1.50₹0.00₹0.00₹0.00₹0.00₹1.50
2022₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00
2021₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹2.50₹0.00₹0.00₹0.00₹0.00₹2.50
2020₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹2.00₹0.00₹0.00₹0.00₹0.00₹0.00₹2.00
2019₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹3.00₹12.00₹0.00₹0.00₹0.00₹0.00₹15.00
2018₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹2.00₹0.00₹0.00₹0.00₹2.00
2017₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹4.50₹0.00₹0.00₹0.00₹4.50
2016₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹4.00₹0.00₹0.00₹0.00₹0.00₹0.00₹4.00
2015₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹3.00₹0.00₹0.00₹0.00₹0.00₹0.00₹3.00
2014₹5.00₹105.00₹0.00₹0.00₹110.00

Dividend Yield & Payout


Dividend Yield
100.0%200.0%300.0%400.0%500.0%600.0%0.4%
Strides Pharma Science Limited has a dividend yield of 0.40%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
200.0%400.0%600.0%800.0%6.7%
Strides Pharma Science Limited has a payout ratio of 6.70%, which is below the market average. This means Strides Pharma Science Limited returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-62.25%
-0.59%
STAR.NS (Strides Pharma Science Limited)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Strides Pharma Science Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Strides Pharma Science Limited was 84.05%, occurring on Mar 9, 2009. Recovery took 310 trading sessions.

The current Strides Pharma Science Limited drawdown is 62.25%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-84.05%Feb 15, 2006756Mar 9, 2009310Jun 14, 20101066
-78.04%Nov 18, 20151600May 12, 2022558Aug 14, 20242158
-70.82%Dec 5, 2012309Mar 3, 2014247Mar 5, 2015556
-65.28%Oct 18, 202466Jan 21, 2025
-60.07%Dec 12, 2003112May 17, 2004267May 31, 2005379

Volatility

Volatility Chart

The current Strides Pharma Science Limited volatility is 21.73%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%SeptemberOctoberNovemberDecember2025February
21.73%
3.18%
STAR.NS (Strides Pharma Science Limited)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Strides Pharma Science Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Strides Pharma Science Limited.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab